May 25, 2021
According to the research report titled ‘GCC Wound Care Market Analysis, 2021’, available with Market Study Report, GCC wound care market share is projected to grow substantially between 2021-2026.
Focus towards research & development activities, growing number of patients suffering from chronic wounds such as venous leg ulcers, diabetic foot ulcers, skin abrasions and cavity wounds, and increasing investment towards improving the healthcare infrastructure are key factors spurring GCC wound care market expansion.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3583514/
Meanwhile, the rising spread of Coronavirus has compelled several healthcare institutions to prioritize COVID-19 patients over wound care treatment, which in turn could potentially act as a bottleneck to the expansion of GCC wound care industry.
Based on product gamut, GCC wound care market is bifurcated into wound care products, wound therapy devices, and functional wound care products. Speaking of end user spectrum, the industry is segmented into hospitals (in-patients, out-patients) and specialty clinics (in-patients, out-patients).
Moving on to application scope, GCC wound care market space is segregated into pressure sores, traumatic ulcers, diabetic foot ulcers, arterials & veins, and burns segments. Among these, the diabetes foot ulcers segment captured majority of the industry share in 2020 owing to its high prevalence and growing efforts by governments to provide free treatment. Furthermore, rising geriatric population and increasing adoption of wound care devices will also aid towards the market expansion.
The report analyses this business domain by highlighting the countries such as Oman, UAE, Bahrain, Qatar, Kuwait and Saudi Arabia. Statistical data pertaining to growth rate, market share projections, sales amassed, and revenue garnered is covered for each country.
Key players influencing GCC wound care market trends are Smith & Nephew plc, Medtronic plc, Coloplast A/S, 3M Gulf Ltd., Mundipharma Middle East FZ-LLC, Integra LifeSciences Middle East FZ-LLC, BSN Medical GmbH and ConvaTec.
These companies have undertaken strategic decisions like investments, product launches, mergers & acquisitions and partnerships to maximize profits and strengthen their foothold in the business sphere.